RA Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $21.8M | Buy |
|
|||||
|
2024
Q4 | $16.1M | Sell |
|
|||||
|
2024
Q3 | $32.5M | Sell |
|
|||||
|
2024
Q2 | $52.2M | Sell |
|
|||||
|
2024
Q1 | $60.3M | Hold |
|
|||||
|
2023
Q4 | $48.4M | Hold |
|
|||||
|
2023
Q3 | $48.4M | Hold |
|
|||||
|
2023
Q2 | $58.5M | Hold |
|
|||||
|
2023
Q1 | $60.1M | Hold |
|
|||||
|
2022
Q4 | $86.3M | Hold |
|
|||||
|
2022
Q3 | $84.1M | Hold |
|
|||||
|
2022
Q2 | $91M | Hold |
|
|||||
|
2022
Q1 | $142M | Hold |
|
|||||
|
2021
Q4 | $206M | Hold |
|
|||||
|
2021
Q3 | $119M | Hold |
|
|||||
|
2021
Q2 | $113M | Buy |
|
|||||
|
2021
Q1 | $151M | Hold |
|
|||||
|
2020
Q4 | $149M | Hold |
|
|||||
|
2020
Q3 | $109M | Buy |
|